Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$360 Mln
Revenue (TTM)
$230 Mln
Net Profit (TTM)
$-65 Mln
ROE
-0.2 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1
Industry P/E
44.78
EV/EBITDA
-5.5
Div. Yield
0 %
Debt to Equity
0.1
Book Value
$--
EPS
$-1.8
Face value
--
Shares outstanding
37,755,200
CFO
$-162.71 Mln
EBITDA
$-259.22 Mln
Net Profit
$-381.90 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
SeaSpine Holdings Corp (SPNE)
| 14.3 | 24.4 | 55.4 | -28.3 | -8.6 | -1.2 | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
SeaSpine Holdings Corp (SPNE)
| -38.7 | -21.9 | 45.3 | -34.2 | 79.7 | 28.1 | -54.0 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
As of January 4, 2023, SeaSpine Holdings Corporation was acquired by Orthofix Medical Inc. SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment... of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California. Read more
Pres, CEO & Director
Mr. Keith C. Valentine
Pres, CEO & Director
Mr. Keith C. Valentine
Headquarters
Carlsbad, CA
Website
The share price of SeaSpine Holdings Corp (SPNE) is $9.54 (NASDAQ) as of 06-Jan-2023 09:30 EDT. SeaSpine Holdings Corp (SPNE) has given a return of -8.64% in the last 3 years.
Since, TTM earnings of SeaSpine Holdings Corp (SPNE) is negative, P/E ratio is not available.
The P/B ratio of SeaSpine Holdings Corp (SPNE) is 0.98 times as on 02-Feb-2023, a 67 discount to its peers’ median range of 2.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
-8.52
|
1.48
|
|
2020
|
-10.91
|
2.74
|
|
2019
|
-5.81
|
2.08
|
|
2018
|
-8.16
|
1.93
|
|
2017
|
-3.78
|
1.15
|
The 52-week high and low of SeaSpine Holdings Corp (SPNE) are Rs -- and Rs -- as of 05-Apr-2026.
SeaSpine Holdings Corp (SPNE) has a market capitalisation of $ 360 Mln as on 02-Feb-2023. As per SEBI classification, it is a Small Cap company.
Before investing in SeaSpine Holdings Corp (SPNE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.